Annovis Bio Inc expected to post a loss of $1.30 a share - Earnings Preview

Annovis Bio

29/03/2024 12:33

* Annovis Bio Inc  ANVS.N   ANVS.K  is expected to show no
change
in quarterly revenue when it reports  results on April 1
(estimated) for the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for Annovis Bio Inc is for a
loss
of $1.30 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Annovis Bio
Inc
is $30.00​, above​ its last closing price of $11.90. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -1.06       -1.09      -1.63     Missed  -49.5
 Jun. 30 2023  -1.11       -1.14      -1.07     Beat    6.3
 Mar. 31 2023  -0.33       -0.33      -1.19     Missed  -256.3
                                                        ​
 Dec. 31 2022  -1.05       -1.05      -0.38     Beat    63.9
 ​​Sep.        -1.02       -1.01      -0.93     Beat    8.2
 30 2022                                                
 Jun. 30 2022  -0.65       -0.64      -1.07     Missed  -65.9​
 Mar. 31 2022  -0.58       -0.58      -0.72     Missed  -24.1
 Dec. 31 2021  -0.25       -0.25      -0.75     Missed  -200
 This summary was machine generated March 29 at 12:33 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)